Measurement of Gait Spatio-Temporal Characteristics in Knee Osteoarthritis Patients

January 23, 2008 updated by: Assaf-Harofeh Medical Center
The purpose of the study is to evaluate the gait spatio-temporal parameters of patients with degenerative changes in the knee joint and to relate them with 2 questionares (WOMAC and SF-36).

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Israel
      • Herzliya, Israel
        • Recruiting
        • APOS Medical Center
        • Contact:
          • Ronen Deby, MD
          • Phone Number: 08-9779432
      • Zrifin, Israel
        • Recruiting
        • "Asaf Harofeh" Medical center
        • Contact:
          • Ronen Deby, MD
          • Phone Number: 08-9779432

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients with knee osteoarthritis evaluated by an orthopedic surgeon. patient will be recruted from the outpatient clinic at "asaf Harofe" medical center, Zrifin, Israel and APOS medical center, Herzlya, Israel

Description

Inclusion Criteria:

  • Symptomatic knee OA for at least 6 months
  • Fulfilled American College of Rheumatology clinical criteria for OA of the knee
  • Radiographically assessed OA of the knee graded 1-4 according to the Kellgren & Lawrence scale

Exclusion Criteria:

  • Acute septic arthritis
  • Patients with an increased tendency to fall
  • Lack of physical or mental ability to perform or comply with the treatment procedure
  • Diabetes mellitus
  • History of pathological osteoporotic fracture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
patient demonstrating degenerative changes in the knee joint (osteoarthritis)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assaf-Harofeh Medical Center

Investigators

  • Study Chair: Nahum Halperin, Prof (MD), "asaf Harofe" Medical Center, Zrifin, Israel

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2008

Primary Completion (Anticipated)

July 1, 2008

Study Registration Dates

First Submitted

January 14, 2008

First Submitted That Met QC Criteria

January 23, 2008

First Posted (Estimate)

January 24, 2008

Study Record Updates

Last Update Posted (Estimate)

January 24, 2008

Last Update Submitted That Met QC Criteria

January 23, 2008

Last Verified

December 1, 2007

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 185/07

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe